The technology combines human ultrasound assessment with automatically extracted image features to classify malignancy risk and flag low-confidence cases for further evaluation.
Phospholipid encapsulation enables enhanced ultrasound contrast and localized delivery of therapeutic gases following hypoxic-ischemic injury.